Table 2.

Clinical trial evaluation scheme.

	−4 Weeks	0 Weeks	12 Weeks
	(baseline)	(single dose)
Ingestion on the test day		⬤
Medical interview	⬤	⬤	⬤
Height	⬤
Weight	⬤	⬤	⬤
Vital Signs	⬤	⬤	⬤
Blood sampling *	⬤		⬤
Uchida–Kraepelin Test	⬤	⬤	⬤
Cognitrax test	⬤	⬤	⬤

The evaluations that are marked with circles (⬤) were performed on the day of the test. Tests were performed in the order listed in the table. * Blood samples were collected for hematological tests (white blood cell and red blood cell counts, hemoglobin concentration, hematocrit, platelet count, mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration) and biochemical blood parameter evaluations (total protein, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transpeptidase, lactate dehydrogenase, uric acid, urea nitrogen, total bilirubin, albumin, creatinine, fasting blood glucose, and glycated hemoglobin).